Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8675237 | Progress in Cardiovascular Diseases | 2018 | 9 Pages |
Abstract
Pulmonary embolism (PE) is a leading cause of cardiovascular mortality worldwide. Clinical presentation can be diverse, and clinicians should have a high index of suspicion regarding the diagnosis. Evaluation should include detailed history of possible risk factors, physical examination and laboratory tests that would support the diagnosis and help risk-stratify patients. Finally, a dedicated imaging study should be performed in order to make a definitive diagnosis. Decisions regarding short-term, immediate, treatment are dictated by PE risk category. Treatment of low and high-risk PE is relatively straightforward. But treating moderate risk PE is challenging since aggressive treatment is not devoid of potential harm. This review focuses on the acute and chronic treatment of PE. We present risk stratification, guidance as to treatment choice and insights into chronic treatment with available anticoagulants.
Keywords
CTAECMOIVCFDOACINRLMWHUFHCDTVKAPERTTTESSPEPulmonary embolismvitamin K antagonistCT angiographyOxygenExtra corporeal membrane oxygenationTrans-thoracic echocardiographyICUintensive care unitright ventricleDVTDeep vein thrombosiscomputed tomographyDUSIntracranial hemorrhageThrombolytic therapyDoppler ultrasoundPulmonary Embolism Severity IndexDirect oral anticoagulantinferior vena cava filterliterICHmilligramnanogramInternational Normalized RatioLow molecular weight heparinunfractionated heparinPESIpicogramCatheter directed thrombolysis
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Ariel Borohovitz, Mitchell D. Weinberg, Ido Weinberg,